Genetic variants of microsomal metabolism and susceptibility to hydrocarbon-associated glomerulonephritis

QJM: An International Journal of Medicine

Volumn 90, Issue 11, 1997, Pages 693-698

  Pai, P ^a,c   Hindell, P ^b   Stevenson, A ^b   Mason, H ^b   Bell, G M ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b HEALTH AND SAFETY LABORATORY   (United Kingdom)

^c SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CELL DNA; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; HYDROCARBON;

ARTICLE; BIOTRANSFORMATION; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXPOSURE; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; KIDNEY MICROSOME; LEUKOCYTE; MALE; METABOLISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0030830245     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.11.693     Document Type: Article

References (38)

1. Crisp AJ, Bhalla AK, Hoffbrand BL. Acute tubular necrosis after exposure to diesel oil. Br Med J 1979; 2:177.
2. Narvarte J, Saba SR, Ramirez G. Occupational exposure to organic solvents causing chronic tubulointerstitial nephritis. Arch Intern Med 1989; 149:154-9.
3. Bell GM, Gordon ACH, Lee P, et al. Proliferative glomerulonephritis and exposure to organic solvents. Nephron 1985; 40:161-5.
4. Cagnoli I, Cassanova S, Pasquali S, Donini U, Zucchelli P. Relationship between hydrocarbon exposure and the nephrotic syndrome. Br Med J 1980; 280:1968-9.
5. Ehrenreich T, Yunis SL, Churg J. Membranous nephropathy following exposure to volatile hydrocarbons. Environ Res 1977; 14:35-45.
6. Beirne GJ, Brennan JT. Glomeulonephritis associated with hydrocarbon solvents. Arch Environ Health 1972; 25:365-9.
7. Kleinknecht D, Morel-Maroger L, Callard P, Adhemar J-P, Mahieu P. Antiglomerular basement membrane nephritis after solvent exposure. Arch Intern Med 1980; 140:230-2.
8. Hotz P, Pilliod J, Soderstrom D, Rey F, Boillat MA, Savolainen H. Relation between renal function tests and a retrospective organic solvent exposure score. Br J Indust Med 1989; 46:815-19.
9. Ravnskov U, Gorsberg B, Skerfving S. Glomerulonephritis and exposure to organic solvents. A case control study. Acta Med Scand 1979; 205:575-9.
10. Finn R, Fennerty AG, Ahmad R. Hydrocarbon exposure and glomerulonephritis. Clin Nephrol 1980; 14:173-5.
11. Ravnskov U, Lundstrom S, Norden A. Hydrocarbon exposure and glomerulonephritis: Evidence from patient's occupations. Lancet 1983; 2:1214-16.
12. Ogawa M, Mori T, Mori Y, et al. Study on chronic injuries induced by carbon tetrachloride. Selective inhibition of the nephrotoxicity by irradiation. Nephron 1992; 60:68-73.
13. Heymann W, Hackel DB, Harwood S, Wilson SGF, Hunter JLP. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspension. Proc Soc Exp Biol Med 1959; 100:660-4.
14. Edgington TS, Glassock RJ, Dixon F. Autologous immune complex nephritis induced with renal tubular antigens. 1. Identification and isolation of the pathogenetic antigen. J Exp Med 1968; 127:555-71.
15. Zimmermann SW, Groehler K, Beirne GJ. Hydrocarbon exposure and chronic glomerulonephritis. Lancet 1975; 2:199-201.
16. Thornton-Manning JR, Gao P, Lilly PD, Pegram RA. Acute bromodichlormethane toxicity in rats pretreated with cytochrome P450 inducers and inhibitors. Toxicologist 1993; 13:361.
17. Lash LH. Role of metabolism in chemically induced nephrotoxicity. In: Goldstein RS, ed. Mechanisms of injury in renal disease and toxicity. CRC Press, 1994:207-34.
18. McCarthy RI, Lock EA, Hawksworth GM. Cytosolic C-S lyase activity in human kidney samples - relevance for the nephrotoxicity of halogenated alkenes in man. Toxicol and Indust Health 1994; 10:103-12.
19. Smith CAD, Gough AC, Leigh PN, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992; 339:1375-7.
20. Gonzalez FJ and Gelboin HV. Role of human cytochrome P 450s in risk assessment and susceptibility to environmentally based disease. J Toxicol Environ Health 1993; 40:289-308.
21. Daly AK, Cholerton S, Gregory W, Idle JR. Metabolic polymorphisms. Pharmacol Ther 1993; 57:129-60.
22. Goldstein JA, Faletto MB. Advances in mechanisms of activation and deactivation of environmental chemicals. Environ Health Perspect 1993; 100:169-76.
23. Hayes PC, Bouchier IAD, Beckett GJ. Glutathione S-transferase in humans in health and disease. Gut 1991; 32:831-8.
24. Schecter RL and Alaoui-Jamali MA. Glutathione S-transferase in chemotherapy resistance and in carcinogenesis. Biochem Cell Biol 1992; 70:349-53.
25. Sies H and Ketterer B, eds. Glutathione conjugation: Mechanisms and biological significance. New York, Academic Press, 1988.
26. Liu YH, Taylor J, Linko P, Lucier GW, Thompson CL. Glutathione S-transferase μ in human lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adducts. Caranogenesis 1991; 12:2269-75.
27. Fost U, Hallier E, Ottenwalder H, Bolt HM, Peter H. Distribution of ethylene oxide in human blood and its implications for biomonitoring. Human & Experimental Toxicol 1991; 10:25-31.
28. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione S-transferase activity on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988; 85:7293-7.
29. Riihimaki V, Savolainen K, Pfaddli P, Pekari K, Sippel HW, Laine A. Metabolic interaction between m-xylene and ethanol. Arch Toxicol 1982; 49:253-6.
30. Elovaara E, Collan Y, Pfaffli P, Vainio H. The combined toxicity of technical grade xylene and ethanol in the rat. Xenobiotica 1980; 10:435-45.
31. Dales L, Feridman G, Sieglaulb AB, Geltzer C, Ury H. Cigarette smoking habits and urine characterisitics. Nephron 1978; 20:163-7.
32. Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase Theta (CSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300:271-6.
33. Lin HJ, Han CY, Lin BK, Hardy S. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 asians, blacks, hispanics and whites: Application to metabolic epidemiology. Am J Hum Genet 1993; 52:827-34.
34. Rodriquez JW, Kirlin JW, Ferguson WG, et al. Human acetylator genotype relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol. Arch Toxicol 1993; 67:445-52.
35. Borlak JT, Harsany V, Schneble H, Haegele KD. pNAT and CYP 2D6 gene polymorphism in epileptic patients. Biochem Pharmacol 1994; 48:1717-20.
36. Ag'undez JAG, Martinez C, Ladero JM, et al. Debrisoquine oxidation genotype and susceptibility to lung cancer. Clin Pharmacol & Therap 1994; 55:10-14.
37. Bondy SC, Lam HR, Ostergaard G, Guo SX, Ladefoged O. Changes in markers of oxidative status in brain, liver and kidney of young and aged rats following exposure to aromatic white spirit. Arch Toxicol 1995; 69:410-14.
38. Stevenson A, Yaqoob M, Mason H, Pai P, Bell GM. Biochemical markers of basement membrane disturbances and occupational exposure to hydrocarbons and mixed solvents. Q J Med 1995; 88:23-8.